近期诊断COVID-19后行全关节置换术的30天死亡率和并发症率:国家COVID队列协作组(N3C)的回顾性队列研究
本研究利用国家COVID队列协作组(N3C)数据,纳入85,047例择期全关节置换术患者,其中3,516例(4.13%)近期COVID-19阳性。分析发现,术前2周内诊断COVID-19的患者肺炎(OR 2.46)、急性心肌梗死(OR 2.90)、90天内脓毒症(OR 2.63)和30天死亡率(OR 10.61)风险增加。作者认为近期诊断COVID-19的患者行全关节置换术前应考虑这些关键数据。
要点
- 择期全关节置换术中4.13%(3,516/85,047)患者近期COVID-19阳性。
- 术前2周内诊断COVID-19者肺炎OR 2.46、急性心肌梗死OR 2.90、90天内脓毒症OR 2.63。
- 上述患者30天死亡率OR高达10.61。
核心结论
- 近期诊断COVID-19后行全关节置换术的患者术后并发症(包括30天死亡率)风险增加。
- 作者认为近期诊断COVID-19的患者行全关节置换术前应考虑本分析提供的关键数据。
研究设计与样本
- 利用国家COVID队列协作组(N3C)数据 enclave 的回顾性队列研究。
- 纳入初次和翻修全髋关节置换术(THA)或全膝关节置换术(TKA)患者,分为COVID-19阳性组(PCR阳性、临床诊断或抗体阳性)和阴性组,并记录诊断时间。
- 共纳入85,047例择期全关节置换术患者,其中3,516例(4.13%)近期COVID-19阳性。
- 原文未提及疾病严重程度或急性度的区分。
主要发现
- 术前2周内诊断COVID-19的患者肺炎风险增加(OR 2.46)。
- 术前2周内诊断COVID-19的患者急性心肌梗死风险增加(OR 2.90)。
- 术前2周内诊断COVID-19的患者90天内脓毒症风险增加(OR 2.63)。
- 术前2周内诊断COVID-19的患者30天死亡率风险增加(OR 10.61)。
临床怎么用
- 作者认为近期诊断COVID-19的患者行全关节置换术前应考虑本分析提供的关键数据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of postoperative complications in patients who had a positive COVID-19 test prior to a total joint arthroplasty (TJA) is unknown. The purpose of this investigation was to study the complications and mortality associated with a recent COVID-19 diagnosis prior to TJA. METHODS: Patients undergoing primary and revision total hip arthroplasties (THAs) or total knee arthroplasties (TKAs) were identified using the National COVID Cohort Collaborative (N3C) Data Enclave. Patients were divided into a COVID-19-positive group (positive polymerase chain reaction [PCR] test, clinical diagnosis, or positive antibody test) and a COVID-19-negative group, and the time from diagnosis was noted. There was no differentiation between severity or acuity of illness available. The postoperative complications reviewed included venous thromboembolism, pneumonia, acute myocardial infarction, readmission rates, and 30-day mortality rates. RESULTS: A total of 85,047 patients who underwent elective TJA were included in this study, and 3,516 patients (4.13%) had had a recent positive COVID-19 diagnosis. Patients diagnosed with COVID-19 at 2 weeks prior to TJA were at increased risk of pneumonia (odds ratio [OR], 2.46), acute myocardial infarction (OR, 2.90), sepsis within 90 days (OR, 2.63), and 30-day mortality (OR, 10.61). CONCLUSIONS: Patients with a recent COVID-19 diagnosis prior to TJA are at greater risk of postoperative complications including 30-day mortality. Our analysis presents critical data that should be considered prior to TJA in patients recently diagnosed with COVID-19. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Pincavitch JD, Pisquiy JJ, Wen S, et al. Thirty-Day Mortality and Complication Rates in Total Joint Arthroplasty After a Recent COVID-19 Diagnosis: A Retrospective Cohort in the National COVID Cohort Collaborative (N3C). J Bone Joint Surg Am. 2023. PMID: 37352338. doi:10.2106/JBJS.22.01317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。